维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="Kopetz S"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Use of research biopsies in clinical trials : Arc risks and benefits adequately discussed 显示文摘	Overman M J Modak J Kopetz S	2013	J Clin Oncol2013，31，：	1
2	First in human phase I study of BSI-201, a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in subjects with advanced solid tumors显示文摘	KOPETZ S MITA M M MOK I	2008	J Clin Oncol2008，26，5：	1
3	Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy显示文摘	Kopetz S Chang GJ Overman MJ	2009	J Clin Oncol2009，27，：	1
4	The promise of patient-derived xen- ografts: the best laid plans of mice and men显示文摘	Kopetz S Lemos R Powis G	2012	Clin Cancer Res2012，18，19：	1
5	The SRC family of protein tyrosine kinases : a new and promising target for eolorectal canc- er therapy显示文摘	Lieu C Kopetz S	2010	Clin Colorectal Cancer2010，9，2：	1
6	Improved survival in metastatic colorectal cancer is associated with adoption of he- patic resection and improved chemotherapy 显示文摘	Kopetz S Chang GJ Overman MJ	2009	J Clin Oncol2009，27，22：	1
7	Immunophenotype and mo-lecular characterisation of adenocarcinoma of the small intestine 显示文摘	Overman MJ Pozadzides J Kopetz S	2010	BrJ Cancer2010，102，1：	1
8	Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel abenocarcinoma 显示文摘	Overman MJ Kopetz S Wen S	2008	Cancer2008，113，8：	1
9	Synergistic activity of theSRC family kinase inhibitor dasatinib and oxaliplatin in coloncarcinoma cells is mediated by oxidative stress显示文摘	Kopetz S Lesslie DP Dallas NA	2009	Cancer Res2009，69，9：	1
10	Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine显示文摘	Overman MJ Pozadzides J Kopetz S	2010	Br J Cancer2010，102，1：	1
11	RAS mu- tation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metasta- ses 显示文摘	VAUTHEY J N ZIMMrITI G KOPETZ S E	2013	Annals of Surgery2013，258，4：	1
12	Improved survival in metastatic eolorectal cancer is associated with adoption of hepatic resection and improved chemotherapy显示文摘	Kopetz S Chang GJ Overmen MJ	2009	J clin Oncol2009，27，22：	1
13	Improved survival in melastatic colorectal cancer is associaled with adoption of he- patic resection and improved chemotherapy 显示文摘	Kopetz S Chang G J Overman M J	2009	J Clin Oncol2009，27，22：	1
14	Synergistic activity of the src family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress显示文摘	Kopetz S Lesslie D P Dallas N A	2009	Cancer Res2009，69，9：	1
15	Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine显示文摘	Overman MJ Kopetz S Lin E	2010	Acta Oncol2010，49，4：	1
16	Improved survival inmetastatic colorectal cancer is associated with adoption of hepaticresection and improved chemotherapy 显示文摘	Kopetz S Chang GJ Overman MJ	2009	J Clin Oncol2009，27，22：	1
17	Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy 显示文摘	Kopetz S Chang GJ Overman M J	2009	J Clin Oncol2009，27，22：	1
18	Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine 显示文摘	Overman MJ Kopetz S Lin E	2010	Acta Oncol2010，49，4：	1
19	Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy显示文摘	Kishi Y Kopetz S Chun YS		0，，03：	1
20	Chemotherapy with 5-fluorouracil and a platinum compound improves outcones in metastatic small bowel adenocarcinoma显示文摘	Overman MJ Kopetz S Wen S	2008	Cancer2008，113，8：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示